i think traderlily stopped following news on the company since the mid - 2000's also...
- no deals on table until after trial results announced
- FDA considering fast-tracking any AD drug that proves safety and some cognition/memory benefit
- PBT2 has completed 12 month trial and now in 12 month open label.. Once imagine results are announced will have about 6 months of research in extension that can be openly discussed.
- Once extension trial is complete - it will be 2 years of safety and tolerability test with expected signs of cognition gains as indicated in Reach2HD and previous AD trial.
- Statement that extension trial was intitiated at request of treating physicians.
- TT interview with wife of a AD sufferer in a drug trial ( which is implied to be PBT2 ) stating it is a "godsend"
- various upgraded price targets for Reach2HD results of $20-30 ( NASDAQ ) .. HD is a $850,000,000 market. AD is conservatively estimated at around $10,000,000,000.
- prices dont reflect recent announcement that PBT2 successfully reduced age related memory loss in animal trials.
im long... i believe in the above, and have based risk/reward likewise...
if one is so scared of the potential of the company, they can always hold shares of a different one instead of raising concerns on old news and trade swings.
- Forums
- ASX - By Stock
- ATH
- h c wainwright analyst
h c wainwright analyst, page-29
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $7.487K | 2.477M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
67 | 113828933 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 4742745 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
66 | 113378933 | 0.002 |
27 | 141240147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 4742745 | 1 |
0.004 | 141306657 | 51 |
0.005 | 10337350 | 17 |
0.006 | 18198914 | 17 |
0.007 | 52406651 | 23 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online